Log in
Enquire now
‌

US Patent 11166993 Methods for celiac disease using lactobacillus strains

Patent 11166993 was granted and assigned to Probi AB on November, 2021 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Patent abstract

The present invention relates to at least one probiotic strain of Lactobacillus for use in a subject for the prevention and/or treatment of celiac disease autoimmunity (CDA), or for use in the prevention and/or treatment of celiac disease (CD).

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11166993 Methods for celiac disease using lactobacillus strains

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.